openPR Logo
Press release

Pharmaveda revolutionizing the field of indigenous medicine

08-18-2021 03:24 PM CET | Health & Medicine

Press release from: India PR Distribution



India, 13th August 2021:- Pharmaveda is a company developing and manufacturing specialty ayurvedic medicines that have revolutionized the field of indigenous medicine from just hypothesis to proof in light of modern understanding of human physiology, biochemistry & pharmacological sciences. The Pharmaveda team consists of reputed scientists, researchers, doyens of the Indian Pharma Industry with huge experience, management experts, and administrative professionals. The company’s mission is to answer basic questions about ayurvedic medicines like what is their site and mode of action, in a language understood by modern sciences.
Ayurvedic medicines have been proved to improve longevity, enhance strength, and rejuvenate the body with very few incidences of side effects, due to their natural botanical & mineral origin. Pharmaveda has been very popular because of the way its products are developed. They blend the traditional knowledge and wisdom drawn over the centuries about Ayurveda, with modern research to combine them into products. The company follows safe manufacturing practices and has an in-house quality assurance lab with sophisticated analytical instruments under the leadership of Dr. Shefali Tungare, the Director of Quality Assurance.
Their product range has a variety of medicines like P-28, P2G, Psyllivac, Remaav, Detoxina, flo, Lomotral, Motabs, Capello etc. Team Pharmaveda has done pioneering work in immune-potentiation with ayurvedic medicines which lead to the development of the immune boosting medicine – Reimun. The clinical evaluation of Reimun as a stand-alone treatment modality in severely immunodeficient patients afflicted with HIV/AIDS & TB, has been conducted in various premier teaching medical intuitions of repute in India, and the data from these studies have been presented and accepted in major medical conferences across the globe.
Made with immunomodulatory ingredients like Katira, Chorak, Dudhal, Lalongo, giloy & ashwagandha, bhasma, etc., Reimun is a globally renowned immunity booster that has been approved by the FDA and has been in the market for 23 years without any reported sideeffects. The product (whose clinical trials showed that no patient displayed any adverse effects after even five years of follow-up) is produced in a cGMP, ISO 22000:2005, HACCP certified manufacturing facility, assuring the quality and safety of it.
The body of immune-boosting evidence in terms of robust clinical trials is what separates Reimun from claims by others. In fact, the Medicine Updates volumes of 2007, 2014 & 2019, published by the Association of Physicians of India, have also documented the role of Reimun as an immunomodulator in the treatment of tuberculosis including MDR-TB. Moreover, its use as an immunomodulator has also been endorsed by CCRAS, the nodal scientific body of the Government of India’s AYUSH Ministry.
In this era hit by the covid-19 pandemic, Reimun even helps strengthen immune defenses against the virus. Infection with SARS-CoV-2 practically depresses all the WBC subsets, especially all types of lymphocytes with a significant fall in the WBC numbers. Reimun revitalizes and stimulates the bone marrow-thymus axis to increase the generation of new immune cells to replace those that are dying.
Reimun provides several micronutrients such as iron, zinc, calcium, manganese, magnesium along with bioflavonoids, alkaloids, saponins, glycosides, etc. making it safe to be consumed by young and old alike (including geriatric or aged population). In short, Reimun revitalizes our immune system to make it alert and elicit a prompt & robust immune response against invading pathogens to keep people in good health.
Dr. Satish Vaidya, one of the founders of Pharmaveda said,“We have drawn huge inputs from my teachers who were internationally reputed scientists, pharmacologists, biochemists, and practitioners from both modern medical specialties& Ayurveda. Our vision behind creating Pharmaveda was to show the world the holistic approach of Ayurveda which is based on the concept of 3 humors or tridoshas – Vata, Pitta &Kapha – and the balance of it for good health can also be rationally explained in terms of modern-day pharmacology & biochemistry. I wanted to put the well-defined, remarkable, and distinct biological effects of ayurvedic & herbal drugs to good use in the service of our people.”
To learn more, visit:

BS-​4, kamdar Shopping Centre,
Tejpal Road, Vile Parle (E),
Mumbai - 400057

AyushChakra was created to show the world the centuries old practice of Ayurveda through the eyes of Modern Science. The benefits of Ayurveda are known to every Indian.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaveda revolutionizing the field of indigenous medicine here

News-ID: 2358659 • Views: 805

More Releases from India PR Distribution

Poet Prashant Bebaar’s debut book ‘Dareeche’ launched by music maestro Anup Jalota
Poet Prashant Bebaar’s debut book ‘Dareeche’ launched by music maestro Anu …
Dareeche, a collection of poems in Hindustani by Prashant 'Bebaar' gets launched by ghazal and bhajan samrat Anup Jalota Prashant Bebaar, a Hindi-Urdu poet who has been writing for almost two decades has now come up with his debut collection of poems ‘Dareeche’. This collection reached music maestro Anup Jalota in Mumbai and has gained popularity overnight. At a time when Hindi-Urdu literature is seeking revival, more than 1000 copies of

More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications